Variant report
Variant | esv18497 |
---|---|
Chromosome Location | chr1:153069195-153087963 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:97)
- CpG islands (count:244)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr1:153072106-153072249 | Hela-S3 | cervix: | n/a | n/a |
2 | CBX3 | chr1:153072732-153073222 | HCT-116 | colon: | n/a | n/a |
3 | CEBPB | chr1:153072025-153072481 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr1:153072214-153073260 | HCT-116 | colon: | n/a | n/a |
5 | CEBPB | chr1:153070459-153070753 | Hela-S3 | cervix: | n/a | n/a |
6 | CEBPB | chr1:153072593-153073269 | HCT-116 | colon: | n/a | n/a |
7 | CEBPB | chr1:153072809-153073124 | MCF-7 | breast: | n/a | n/a |
8 | CEBPB | chr1:153072685-153073167 | Hela-S3 | cervix: | n/a | n/a |
9 | CHD2 | chr1:153072795-153073086 | Hela-S3 | cervix: | n/a | n/a |
10 | CTCF | chr1:153075160-153075170 | ProgFib | skin: | n/a | n/a |
11 | CTCF | chr1:153075060-153075210 | K562 | blood: | n/a | n/a |
12 | CTCF | chr1:153075120-153075270 | HEK293 | kidney: | n/a | n/a |
13 | CTCF | chr1:153072114-153072181 | LNCaP | prostate: | n/a | n/a |
14 | CTCF | chr1:153075210-153075216 | A549 | lung: | n/a | n/a |
15 | CTCF | chr1:153075219-153075286 | A549 | lung: | n/a | n/a |
16 | CTCF | chr1:153084720-153084870 | HEEpiC | esophagus: | n/a | n/a |
17 | CTCF | chr1:153075100-153075250 | WERI-Rb-1 | eye: | n/a | n/a |
18 | CTCF | chr1:153075177-153075215 | MCF-7 | breast: | n/a | n/a |
19 | CTCF | chr1:153087500-153087650 | WERI-Rb-1 | eye: | n/a | n/a |
20 | CTCF | chr1:153084680-153084830 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr1:153075162-153075244 | LNCaP | prostate: | n/a | n/a |
22 | E2F4 | chr1:153072803-153073112 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | EP300 | chr1:153087855-153088055 | K562 | blood: | n/a | n/a |
24 | EP300 | chr1:153070217-153070881 | Hela-S3 | cervix: | n/a | chr1:153070612-153070626 |
25 | EP300 | chr1:153071976-153073524 | Hela-S3 | cervix: | n/a | n/a |
26 | FOS | chr1:153072180-153073237 | MCF10A-Er-Src | breast: | n/a | chr1:153072839-153072850 |
27 | FOS | chr1:153072065-153073279 | MCF10A-Er-Src | breast: | n/a | chr1:153072839-153072850 |
28 | FOS | chr1:153072067-153073227 | MCF10A-Er-Src | breast: | n/a | chr1:153072839-153072850 |
29 | FOS | chr1:153072164-153073162 | HUVEC | blood vessel: | n/a | chr1:153072839-153072850 |
30 | FOS | chr1:153072269-153073227 | MCF10A-Er-Src | breast: | n/a | chr1:153072839-153072850 |
31 | FOSL1 | chr1:153072612-153073281 | HCT-116 | colon: | n/a | n/a |
32 | FOSL1 | chr1:153072022-153073251 | HCT-116 | colon: | n/a | n/a |
33 | FOSL2 | chr1:153072722-153073051 | MCF-7 | breast: | n/a | n/a |
34 | FOSL2 | chr1:153072627-153073022 | SK-N-SH | brain: | n/a | n/a |
35 | GABPA | chr1:153085049-153085187 | Hela-S3 | cervix: | n/a | n/a |
36 | GATA1 | chr1:153068392-153069584 | PBDE | blood: | n/a | chr1:153069330-153069340 chr1:153069182-153069192 |
37 | GATA1 | chr1:153087420-153088398 | PBDE | blood: | n/a | n/a |
38 | GATA2 | chr1:153087741-153088229 | K562 | blood: | n/a | n/a |
39 | GATA2 | chr1:153072777-153073165 | HUVEC | blood vessel: | n/a | chr1:153072839-153072848 chr1:153073055-153073064 |
40 | GATA2 | chr1:153072139-153072461 | HUVEC | blood vessel: | n/a | n/a |
41 | GTF2F1 | chr1:153072775-153073077 | Hela-S3 | cervix: | n/a | n/a |
42 | JUN | chr1:153072082-153073232 | Hela-S3 | cervix: | n/a | n/a |
43 | JUN | chr1:153072330-153072376 | HepG2 | liver: | n/a | n/a |
44 | JUND | chr1:153072743-153073302 | HCT-116 | colon: | n/a | n/a |
45 | JUND | chr1:153072006-153073254 | Hela-S3 | cervix: | n/a | n/a |
46 | JUND | chr1:153072018-153073294 | HCT-116 | colon: | n/a | n/a |
47 | JUND | chr1:153072071-153072637 | HCT-116 | colon: | n/a | n/a |
48 | JUND | chr1:153087895-153087898 | K562 | blood: | n/a | n/a |
49 | MAFF | chr1:153084530-153084625 | HepG2 | liver: | n/a | n/a |
50 | MAFK | chr1:153084480-153084680 | HepG2 | liver: | n/a | chr1:153084545-153084565 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:153085998-153086048 | AG04450 | lung: | fetal |
2 | chr1:153085649-153085699 | MCF10A-Er-Src | breast: | n/a |
3 | chr1:153085998-153086048 | BJ | skin: | n/a |
4 | chr1:153085998-153086048 | GM12891 | blood: | n/a |
5 | chr1:153085649-153085699 | NH-A | brain: | n/a |
6 | chr1:153085969-153086019 | NT2-D1 | testis: | n/a |
7 | chr1:153085998-153086048 | GM12892 | blood: | n/a |
8 | chr1:153085969-153086019 | SK-N-SH_RA | brain: | n/a |
9 | chr1:153085998-153086048 | HCM | heart: | n/a |
10 | chr1:153085649-153085699 | ECC-1 | luminal epithelium: | n/a |
11 | chr1:153085649-153085699 | SK-N-SH_RA | brain: | n/a |
12 | chr1:153085649-153085699 | HPAEpiC | pulmonary alveolar: | n/a |
13 | chr1:153085998-153086048 | ECC-1 | luminal epithelium: | n/a |
14 | chr1:153085969-153086019 | GM12878 | blood: | n/a |
15 | chr1:153085649-153085699 | Jurkat | blood: | n/a |
16 | chr1:153085152-153085202 | RPTEC | kidney: | n/a |
17 | chr1:153085649-153085699 | SAEC | small airway: | n/a |
18 | chr1:153085998-153086048 | HAEpiC | amniotic membrane: | n/a |
19 | chr1:153085152-153085202 | T-47D | breast: | n/a |
20 | chr1:153085969-153086019 | PANC-1 | pancreas: | n/a |
21 | chr1:153085969-153086019 | U87 | brain: | n/a |
22 | chr1:153085649-153085699 | U87 | brain: | n/a |
23 | chr1:153085969-153086019 | PrEC | prostate: | n/a |
24 | chr1:153085152-153085202 | HRPEpiC | eye: | n/a |
25 | chr1:153085152-153085202 | GM19239 | blood: | n/a |
26 | chr1:153085152-153085202 | SK-N-MC | brain: | n/a |
27 | chr1:153085969-153086019 | GM19239 | blood: | n/a |
28 | chr1:153085998-153086048 | HPAEpiC | pulmonary alveolar: | n/a |
29 | chr1:153085649-153085699 | IMR90 | lung: | fetal |
30 | chr1:153085649-153085699 | GM06990 | blood: | n/a |
31 | chr1:153085152-153085202 | ECC-1 | luminal epithelium: | n/a |
32 | chr1:153085152-153085202 | ProgFib | skin: | n/a |
33 | chr1:153085998-153086048 | MCF-7 | breast: | n/a |
34 | chr1:153085969-153086019 | HUVEC | blood vessel: | n/a |
35 | chr1:153085998-153086048 | AG10803 | skin: | n/a |
36 | chr1:153085152-153085202 | GM12892 | blood: | n/a |
37 | chr1:153085969-153086019 | HIPEpiC | eye: | n/a |
38 | chr1:153085998-153086048 | PFSK-1 | brain: | n/a |
39 | chr1:153085998-153086048 | Jurkat | blood: | n/a |
40 | chr1:153085152-153085202 | HIPEpiC | eye: | n/a |
41 | chr1:153085998-153086048 | GM19239 | blood: | n/a |
42 | chr1:153085969-153086019 | ProgFib | skin: | n/a |
43 | chr1:153085152-153085202 | HepG2 | liver: | n/a |
44 | chr1:153085649-153085699 | HEEpiC | esophagus: | n/a |
45 | chr1:153085649-153085699 | RPTEC | kidney: | n/a |
46 | chr1:153085649-153085699 | NHDF-neo | bronchial: | n/a |
47 | chr1:153085649-153085699 | HRCEpiC | kidney: | n/a |
48 | chr1:153085152-153085202 | A549 | lung: | n/a |
49 | chr1:153085152-153085202 | BE2_C | brain: | n/a |
50 | chr1:153085998-153086048 | Hepatocyte | liver: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SPRR2F | TF binding region |
SPRR2E | TF binding region |
SPRR2F | CpG island |
SPRR2E | CpG island |
ENSG00000203785 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560972491 | chr1:153069208-153069209 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs529906333 | chr1:153069234-153069235 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs189638389 | chr1:153069238-153069239 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs143853807 | chr1:153069282-153069283 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs148382029 | chr1:153069294-153069295 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs551854509 | chr1:153069317-153069318 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs114462629 | chr1:153069340-153069341 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs74133276 | chr1:153069342-153069343 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs560352743 | chr1:153069400-153069401 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs71769658 | chr1:153069406-153069407 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs11581933 | chr1:153069407-153069408 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs114520305 | chr1:153069430-153069431 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs536436281 | chr1:153069431-153069432 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs114302687 | chr1:153069462-153069463 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs185315716 | chr1:153069466-153069467 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs538652183 | chr1:153069482-153069483 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs141129286 | chr1:153069534-153069535 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs11205195 | chr1:153069584-153069585 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs558639984 | chr1:153069593-153069594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572395640 | chr1:153069595-153069596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35114774 | chr1:153069625-153069626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149619711 | chr1:153069653-153069654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200092329 | chr1:153069656-153069657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34048517 | chr1:153069662-153069663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534657637 | chr1:153069686-153069687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77592975 | chr1:153069690-153069691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141564326 | chr1:153069876-153069877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543607287 | chr1:153069888-153069889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563392741 | chr1:153069969-153069970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576964292 | chr1:153069979-153069980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs61811907 | chr1:153070024-153070025 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs190308869 | chr1:153070070-153070071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528069652 | chr1:153070083-153070084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140070830 | chr1:153070131-153070132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529331865 | chr1:153070143-153070144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145495465 | chr1:153070154-153070155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530254774 | chr1:153070163-153070164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181183920 | chr1:153070225-153070226 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs569826108 | chr1:153070270-153070271 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs569106094 | chr1:153070380-153070381 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs552638143 | chr1:153070524-153070525 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs199619030 | chr1:153070548-153070549 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs535332959 | chr1:153070561-153070562 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs565968614 | chr1:153070567-153070568 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs535001619 | chr1:153070645-153070646 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs61811908 | chr1:153070662-153070663 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs111283376 | chr1:153070668-153070669 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs186588698 | chr1:153070708-153070709 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs557150754 | chr1:153070758-153070759 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs189670388 | chr1:153070789-153070790 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:153067400-153070200 | Weak transcription | NHEK | skin |
2 | chr1:153067400-153072000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr1:153068200-153069600 | Enhancers | K562 | blood |
4 | chr1:153068400-153069200 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr1:153068400-153069200 | Enhancers | Hela-S3 | cervix |
6 | chr1:153069200-153070200 | Weak transcription | Hela-S3 | cervix |
7 | chr1:153070200-153072200 | Enhancers | NHEK | skin |
8 | chr1:153070200-153073600 | Enhancers | Hela-S3 | cervix |
9 | chr1:153070400-153070600 | Enhancers | HMEC | breast |
10 | chr1:153070800-153072000 | Weak transcription | HMEC | breast |
11 | chr1:153072000-153072600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr1:153072000-153072600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr1:153072000-153072800 | Enhancers | HMEC | breast |
14 | chr1:153072200-153072600 | Flanking Active TSS | NHEK | skin |
15 | chr1:153072600-153073400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr1:153072600-153073800 | Enhancers | NHEK | skin |
17 | chr1:153072600-153077600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr1:153072800-153073400 | Weak transcription | HMEC | breast |
19 | chr1:153073400-153073600 | Enhancers | HMEC | breast |
20 | chr1:153073400-153073800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr1:153075400-153075600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr1:153075600-153075800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
23 | chr1:153075800-153076000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
24 | chr1:153077600-153079200 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
25 | chr1:153079200-153080200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
26 | chr1:153085000-153086400 | Enhancers | Ovary | ovary |
27 | chr1:153086000-153086200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
28 | chr1:153086000-153086400 | Enhancers | K562 | blood |
29 | chr1:153086400-153087400 | Weak transcription | K562 | blood |
30 | chr1:153086400-153087600 | Weak transcription | Ovary | ovary |
31 | chr1:153087400-153088000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
32 | chr1:153087400-153088400 | Enhancers | K562 | blood |
33 | chr1:153087600-153088000 | Enhancers | Ovary | ovary |
34 | chr1:153087600-153088000 | Enhancers | NHEK | skin |